- Vouliez-vous dire
- rna, messages
Résultats de la recherche - 5 results
Vaccine effectiveness against COVID-19 hospitalisation in adults (≥ 20 years) during Omicron-dominant circulation: I-MOVE-COVID-19 and VEBIS SARI VE networks, Europe, 2021 to 2022.
Vaccines Europe Hospitalization Humans Pneumonia RNA, Messenger SARS-CoV-2 Vaccine Efficacy Abstract: IntroductionThe I- MOVE- COVID-19 and VEBIS hospital networks have been measuring COVID-19 vaccine ...
Third dose of COVID-19 mRNA vaccine closes the gap in immune response between naïve nursing home residents and healthy adults.
Antibodies, Viral BNT162 Vaccine Breakthrough Infections COVID-19 COVID-19 Vaccines Humans Immunity nursing homes Population Groups RNA, Messenger SARS-CoV-2 Abstract: BACKGROUND: Nursing home residents, ...
Insights From Early Clinical Trials Assessing Response to mRNA SARS-CoV-2 Vaccination in Immunocompromised Patients.
RNA, Messenger SARS-CoV-2 Vaccination Vaccines, Synthetic Abstract: It is critical to protect immunocompromised patients against COVID-19 with effective SARS-CoV-2 vaccination as they have an increased ...
Reduced humoral immune response after BNT162b2 coronavirus disease 2019 messenger RNA vaccination in cancer patients under antineoplastic treatment.
5 (2021) Keywords: Antineoplastic Agents BNT162 Vaccine COVID-19 COVID-19 Vaccines Humans Immunity, Humoral Neoplasms Prospective Studies RNA, Messenger SARS-CoV-2 Vaccination Abstract: BACKGROUND: Cancer ...
HPV DNA genotyping, HPV E6*I mRNA detection, and p16INK4a/Ki-67 staining in Belgian head and neck cancer patient specimens, collected within the HPV-AHEAD study
tests; mRNA; p16(INK4a) Humans Ki-67 Antigen Male middle aged Oncogene Proteins, Viral Papillomavirus Infections RNA, Messenger Staining and Labeling Abstract: BACKGROUND: The main risk factors for head ...